pocketful logo light
pocketful logo light
Sandu Pharmaceuticals Ltd logo

Sandu Pharmaceuticals Ltd

NSE: BSE: 524703

₹37.01

(2.30%)

Tue, 15 Sept 2026, 09:57 am

Sandu Pharmaceuticals Share Price Live Chart

1 Day

(2.30%)

No Result Found

Summary

  • Market Cap (in Cr)

    40.58

  • Net Profit (in Cr)

    1.55

  • P/B

    1.41

  • Sector P/E

    33.76

  • P/E

    30.43

  • EV/EBITDA

    15.24

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    4.74

  • ROCE

    6.87

  • Debt/Equity

    0

  • EPS (TTM)

    1.61

  • Dividend Yield

    1.90

  • Book Value

    34.63

  • Interest Cover

    22.60

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters37.7937.7942.9042.9042.90
FII00000
DII0.010.010.010.010.01
Public62.2162.2157.0957.0957.09
Government00000

Read More

Technical Analysis

RSI

42.50

MACD

-0.36

50 DMA

38.93

200 DMA

38.37

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic52.1744.8241.2837.4733.9330.1222.77
Fibonacci44.8242.0140.2737.4734.6632.9230.12
Camarilla39.7739.1038.4237.4737.0836.4035.73

Pivots Level: Classic

R3

+14.70

52.17

R2

+7.35

44.82

R1

+3.82

41.28

37.47
37.47
Pivot Point
LTP: 36.99

S1

-3.53

33.93

S2

-7.35

30.12

S3

-14.70

22.77

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    37.71

  • 20-EMA

    37.95

  • 30-EMA

    38.23

  • 50-EMA

    38.71

  • 100-EMA

    39.16

  • 200-EMA

    40.26

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
05 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
06 Feb 2026board-meetingsQuarterly Results
18 Aug 2025dividendFinal Dividend - Rs. - 0.818 Sept 2025
13 Aug 2025agm
28 May 2025dividend₹0.80 Dividend /Share18 Sept 2025
12 Aug 2024agm
12 Aug 2024dividend₹0.80 Dividend /Share20 Sept 2024
12 Aug 2023agm
12 Aug 2023dividend₹0.75 Dividend /Share19 Sept 2023
12 Aug 2022agm

Read More

Peer Comparison

Sandu Pharmaceuticals Ltd logo

Sandu Pharmaceuticals Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Sandu Pharmaceuticals Ltd About

Sandu Pharmaceuticals is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. e company has its manufacturing plant in Goa.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1985

Headquarters

CEO

Balaram Vishwanathan

Employees

Contact

Website icon

Website

http://www.sandu.in

Email icon

Email

corp.sec@sandu.in

Phone icon

Phone

Location icon

Location

Plot No 25/26/29 & 30, Pilerne Indl Estate Marra Bard, Bardez, Goa, 403511

Read More

Sandu Pharmaceuticals Ltd Company History

YearHistory
1899
  • Sandu Brothers started the manufacture of Ayurvedic medicines on 10th May.
2000
  • Sandu earned ISO 9001:2000 certification for its Group operations.
2024

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
DPS TRADELINK PRIVATE LIMITEDbulkSell10406155.8519 Mar 2024
TRANS SCAN SECURITIES PVT LTDbulkBuy10600055.8819 Mar 2024
PORINJU VELIYATHbulkSell4350051.9909 Jul 2021
REENA JASVANTBHAI JANIbulkBuy450007.7520 Mar 2009
AMI STOCK SHARE BROKERS PLTDbulkSell450017.8820 Mar 2009
RAMESH G GOKANIbulkBuy450007.8517 Mar 2009
RAMESH G GOKANIbulkSell450007.9509 Feb 2009
AMI STOCK SHARE BROKERS PLTDbulkBuy450007.9509 Feb 2009
RAMESH G GOKANIbulkBuy450008.430 Jan 2009
AMI STOCK SHARE BROKERS PLTDbulkSell450008.430 Jan 2009

Read More

Sandu Pharmaceuticals Ltd News

Sandu Pharma appoints Dave & Dave as statutory auditors

Sandu Pharmaceuticals has appointed M/s Dave & Dave as its statutory auditors for a five-year term starting FY27. The appointment follows the expiry of the tenure of outgoing auditors M/s Dileep and Prithvi.

12 Sept 2026

companies

Sandu Pharma AGM: Viswanathan redesignated CMD

Sandu Pharmaceuticals shareholders approved key resolutions at its 41st AGM, including the redesignation of Balram Viswanathan as CMD and approval of related-party transactions.

11 Sept 2026

companies

Sandu Pharmaceuticals AGM on Sep 11

Sandu Pharmaceuticals has scheduled its 41st Annual General Meeting for September 11, 2026. The meeting will be held via video conference to discuss the annual report for FY26.

20 Aug 2026

companies

Sandu Pharmaceuticals to consider MD appointment

Sandu Pharmaceuticals board will meet on July 11, 2026, to appoint a new Managing Director following the demise of Shri Umesh B. Sandu and reconstitute board committees.

06 Jul 2026

companies

Sandu Pharmaceuticals MD Umesh Sandu passes away

Sandu Pharmaceuticals Managing Director Shri Umesh Sandu passed away on June 19, 2026. He was a promoter and held 13,88,693 shares.

19 Jun 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Sandu Pharmaceuticals Ltd?

    As of 15/09/2026 at 3:27 PM, Sandu Pharmaceuticals Ltd shares are trading at ₹37.01.

  • 2.What is the market cap. of Sandu Pharmaceuticals Ltd?

    As of 15/09/2026, the market capitalization of Sandu Pharmaceuticals Ltd is ₹35.76 crore.

  • 3.When was Sandu Pharmaceuticals Ltd founded?

    Sandu Pharmaceuticals Ltd was founded in 1985.

  • 4.What are the P/E and P/B ratios of Sandu Pharmaceuticals Ltd?

    As of 15/09/2026, Sandu Pharmaceuticals Ltd has a P/E ratio of 20.19 and a P/B ratio of 1.41.

  • 5.How can I buy shares of Sandu Pharmaceuticals Ltd?

    You can buy shares of Sandu Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.Does Sandu Pharmaceuticals Ltd pay dividends?

    Yes, Sandu Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 0.8 per share.

  • 7.What is the dividend yield of Sandu Pharmaceuticals Ltd?

    As of 15 September, 2026, the dividend yield of Sandu Pharmaceuticals Ltd stands at 2.16%.

  • 8.What are the latest financial results of Sandu Pharmaceuticals Ltd?

    For January,2024, Sandu Pharmaceuticals Ltd reported revenue of ₹67.19 crore and a net profit of ₹1.55 crore.

  • 9.Who is the CEO of Sandu Pharmaceuticals Ltd?

    The CEO of Sandu Pharmaceuticals Ltd is Balaram Vishwanathan.

Open Your Free Demat Account

Enter your phone number